FMP
Nexien BioPharma, Inc.
NXEN
PNK
Nexien BioPharma, Inc. operates as a pharmaceutical company. It focuses on the formulation, development, and commercialization of cannabinoid-based pharmaceuticals, and pre-clinical and clinical pathways for the treatment of various diseases, medical conditions, and disorders. The company was formerly known as Intiva BioPharma Inc. and changed its name to Nexien BioPharma, Inc. in September 2018. Nexien BioPharma, Inc. is based in Glendale, Colorado.
0.0167 USD
0.0004 (2.4%)
About
ceo
Mr. Richard S. Greenberg
sector
Healthcare
industry
Drug Manufacturers - Specialty & Generic
website
https://www.nexienbiopharma.com
exchange
PNK
Description
Nexien BioPharma, Inc. operates as a pharmaceutical company. It focuses on the formulation, development, and commercialization of cannabinoid-based pharmaceuticals, and pre-clinical and clinical pathways for the treatment of various diseases, medical conditions, and disorders. The company was formerly known as Intiva BioPharma Inc. and changed its name to Nexien BioPharma, Inc. in September 2018. Nexien BioPharma, Inc. is based in Glendale, Colorado.
CIK
0001625288
ISIN
US65343D1000
CUSIP
65343D100
Address
4340 East Kentucky Avenue
Phone
303 495 7583
Country
US
Employee
N/A
IPO Date
Nov 29, 2017
Key Executives
